title: Vedolizumab in Inflammatory Bowel Disease Associated with Autoimmune Liver Disease Pre- and Postliver Transplantation: A Case Series.
authors.affiliation: *Gastroenterology Department, King's College Hospital, London, United Kingdom †Gastroenterology Department, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom ‡Institute of Liver Studies, King's College Hospital, London, United Kingdom.
authors.forename: Tiong Yeng
authors.initials: TY
authors.lastname: Lim
authors.forename: Polychronis
authors.initials: P
authors.lastname: Pavlidis
authors.forename: Shraddha
authors.initials: S
authors.lastname: Gulati
authors.forename: Tasneem
authors.initials: T
authors.lastname: Pirani
authors.forename: Mark
authors.initials: M
authors.lastname: Samaan
authors.forename: Guy
authors.initials: G
authors.lastname: Chung-Faye
authors.forename: Patrick
authors.initials: P
authors.lastname: Dubois
authors.forename: Peter
authors.initials: P
authors.lastname: Irving
authors.forename: Michael
authors.initials: M
authors.lastname: Heneghan
authors.forename: BuʼHussain
authors.initials: B
authors.lastname: Hayee
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D015209:Cholangitis, Sclerosing / Q000601:surgery*; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications* / Q000188:drug therapy*; D016031:Liver Transplantation; D008131:London; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C543529:vedolizumab